Trial intelligence / Profile preview

Pilot study of tumor concentrations of protein kinase inhibitors in newly diagnosed high-grade glioma

NL-OMON47042Recruiting

Sponsor
Vrije University Medical Center
Start
Jan 2015
Countries
1
01

Overview

Open-label trial in glioma and brain cancer (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Tumor PKI concentration. Started Jan 2015; status: recruiting.

02

Conditions

gliomabrain cancer

Beyond the preview

Go deeper on NL-OMON47042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON47042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call